Replies to post #31630 on Marker Therapeutics Inc (MRKR)

[D_rwc]

I think the end goal will be to characterize the antigens on a per-patient basis so that the treatment exactly fits the condition.

That is probably in the distant future but this work can lead there.

I don't know if that helps (probably not).